X4 Pharmaceuticals, Inc (XFOR) stock
XFORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$2.98−0.11 (-3.56%)
Close on Nov 18, 2026Market cap $295.46MP/E –Yield –
X4 Pharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
X4 Pharmaceuticals's pe ratio was 0.8× on Jul 31, 2025.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jul 31, 2025 | 0.8× | – |
See a number that looks wrong?